Piet Van Waes
MD & Founder @ Tilleghem
Ghent, Belgium
Piet Van Waes is a seed investor at Tilleghem in Ghent focused on Hotel and Medical. Piet Van Waes is the Managing Director and Founder of Tilleghem. He previously worked at Green Park Investment Partners as a Partner. Piet Van Waes attended KU Leuven.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Piet Van Waes invests in
Stages Piet Van Waes invests in
Countries Piet Van Waes invests in
Round sizes
Round size
- Seed
- $1M–$2.4M
Investment Focus
Industry
- Hotel 1 (25%)
- Medical 1 (25%)
- Tourism 1 (25%)
- Software 1 (25%)
- Consulting 1 (25%)
Stage
- Seed 3 (75%)
- Pre-Seed 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Exhibitly.ai
|
Exhibitly.ai provides an AI‑powered platform for trade shows and B2B conferences that personalizes visitor experiences on event websites. Generates tailored exhibitor and session recommendations using attendee job title and company inputs. Converts anonymous website traffic into higher‑intent leads for event organizers. | $1.6M / Pre-Seed / May 19, 2026 | |
Tinrate
|
Tinrate is an easy-to-use connection that allows instructors, experts, and artists to be booked and paid immediately for their services. It serves as a link between your audience and your bank account rather than being a platform full of | $1.9M / Seed / Jan 16, 2026 | |
Rookoo
|
Rookoo offers an AI-driven platform that serves as a digital co-worker for event, hospitality, and tourism teams. The company's intelligent agent is an expert AI event planner/manager that handles all customer inquiries. It acts as a 24/7 front desk, managing initial intake, checking calendars against platforms like Yesplan,Tripleseat, and SevenRooms, and integrating seamlessly with the user's CRM. | $1M / Seed / Nov 14, 2025 | |
Allegro Biotech
|
Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells). | $2.4M / Seed / Jul 03, 2025 |
Co-Investors
About Tilleghem
Tilleghem is a private equity firm that focuses on minority and majority stakes in various enterprises. The company specializes in private equity and real estate projects, providing investment and business development services. Tilleghem aims to achieve immediate and direct CO2 reduction and cost savings on electricity bills for its clients. Thefirm operates with a hands-on approach to investment, ensuring active participation in the growth and development of the companies it invests in.
Tilleghem Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Piet Van Waes
MD & Founder
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Piet Van Waes invest in?
Piet Van Waes invests primarily in Hotel, Medical and Tourism startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Piet Van Waes's check size?
Piet Van Waes typically joins rounds of $1M–$2.4M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Piet Van Waes participates in.
When did Piet Van Waes last invest?
The most recent investment recorded for Piet Van Waes closed in May 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
